Stock Analysis
LivaNova PLC (LIVN) Stock Analysis
LivaNova PLC (LIVN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
LivaNova PLC (LIVN) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 83/100. Value is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
LIVN at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $94.54 |
| AIQ Score | 71/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $5.03B |
| P/E Ratio (TTM) | 25.68 |
| Forward P/E | — |
| EPS (Q3 FY2026) | $0.62 |
| Revenue (Q3 FY2026) | $393.1M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.09 |
| Volume | 1.32M |
| 52-week range | $52.37-$99.38 |
| RSI 14 | 65.47 |
| 50-Day SMA | $80.32 |
| 200-Day SMA | $74.18 |
| Analyst Price Target | $107.50 |
| Next Earnings | Feb 24, 2027 |
LIVNLivaNova PLC
Healthcare / Medical - Devices
Leader
Strong Relative Position
Latest quote
- Momentum83
- Value60
- Quality64
- Risk resilience71
- Sentiment—
LIVN Stock Analysis Summary
LivaNova PLC (LIVN) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 83/100. Value is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, LIVN has AIQ Score of 71/100 with Momentum base of 83/100 and fading Value at 60/100. Wait for component alignment before adding exposure.
Momentum (83/100) leads while Value (60/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 2.85% stock move · LIVN classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is LIVN Bullish or Bearish Right Now?
LIVN currently has a bullish overall setup. Momentum is the strongest factor at 83/100, while Value is weakest at 60/100. The current evidence suggests a constructive setup.
- - Momentum is constructive at 83/100.
- - Risk Resilience is supportive at 71/100.
- - Price is +13.69% above its 50-day SMA.
- - Analyst target implies +13.71% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 1).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
LIVN's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 10 neutral, and 1 sell votes. LIVN's 14-day RSI is 65.47, which places the stock in a constructive momentum range. LIVN's beta is 1.09, indicating market sensitivity broadly in line with the market.
What Changed in LIVN?
The largest recent change in LIVN is Value moving down by 3.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the LIVN Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
LIVN Decision Framework
Public evidence layers, setup checks, and risk context for LivaNova PLC.
LivaNova PLC (LIVN) Stock Analysis
LivaNova PLC has an AIQ Score of 71/100 in a Bullish regime. Momentum is strongest at 83/100. Beta is 1.09, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | LIVN is in a Bullish AIQ regime with score 71/100. |
| Signal Conflict | The primary conflict is that momentum leads at 83/100 while value lags at 60/100. |
| Factor Evidence | Momentum 83/100 · Value 60/100 · Quality 64/100 · Risk 71/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 83/100.
Momentum is 83/100 and RSI (14) is 65.5.
LIVN is in a Bullish regime at 71/100.
Risk factor is 71/100 with beta 1.09 and annual volatility 39.16%.
Current conflict: momentum leads at 83/100 while value lags at 60/100.
LIVN Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
LIVN Fundamentals
LIVN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
LIVN Technical Analysis
LIVN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
LIVN Stock Catalysts
Track LIVN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
LIVN Dividend Analysis
LIVN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
LIVN Financial Data
LIVN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
LIVN Risk Analysis
LIVN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
LIVN Stock News
LIVN stock news, market tone, recent headlines, and catalyst context.
LIVN vs Medical - Devices Peers
Current peer cohort: LIVN · NEOG · PACB · PEN · PHG. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| LIVN Current stock | 71/100 | 60/100 | 83/100 | 71/100 | 1.38 | 39.16% | Current |
| NEOG Neogen Corporation | 63/100 | 49/100 | 74/100 | 57/100 | 1.19 | 57.93% | LIVN vs NEOG |
| PACB Pacific Biosciences of California, Inc. | 48/100 | 23/100 | 84/100 | 24/100 | 0.61 | 93.55% | LIVN vs PACB |
| PEN Penumbra, Inc. | 66/100 | 48/100 | 56/100 | 92/100 | 0.62 | 19.46% | LIVN vs PEN |
| PHG Koninklijke Philips N.V. | 72/100 | 80/100 | 72/100 | 73/100 | 0.18 | 29.69% | LIVN vs PHG |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for LIVN: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching LIVN
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for LIVN
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
LIVN Stock FAQ
What is LIVN stock price today?
LivaNova PLC's current stock price is $94.54. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is LIVN bullish or bearish right now?
LIVN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is LIVN's market cap?
LIVN's market cap is $5.03B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is LIVN's current P/E ratio?
LIVN's current P/E ratio is 25.68 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is LIVN's RSI?
LIVN's 14-day RSI is 65.47 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is LIVN above its 50-day and 200-day moving averages?
LIVN is 13.69% from its 50-day SMA and 23.10% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is LIVN's next earnings date?
LIVN's next earnings date is currently listed as Feb 24, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does LIVN pay a dividend?
LIVN's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.